{"id":1263,"date":"2021-06-01T22:38:30","date_gmt":"2021-06-01T22:38:30","guid":{"rendered":"https:\/\/www.hospitalinnovate.org\/covid19\/?page_id=1263"},"modified":"2021-06-02T00:32:11","modified_gmt":"2021-06-02T00:32:11","slug":"endnotes","status":"publish","type":"page","link":"https:\/\/www.hospitalinnovate.org\/covid19\/clinical-pathways-and-documentation\/clinical-pathways-overview\/endnotes\/","title":{"rendered":"Endnotes"},"content":{"rendered":"

[vc_row full_width=”stretch_row_content_no_spaces” equal_height=”yes” content_placement=”bottom” css=”.vc_custom_1601575873299{margin-top: 0px !important;margin-bottom: 0px !important;border-bottom-width: 4px !important;padding-top: 0px !important;padding-right: 20px !important;padding-bottom: 0px !important;padding-left: 20px !important;background-color: #f2f2f2 !important;border-bottom-color: #2c5d73 !important;border-bottom-style: solid !important;}”][vc_column width=”1\/2″ css=”.vc_custom_1599240993465{padding-right: 20px !important;padding-left: 10px !important;}”][cesis_icon_paragraph heading=”Clinical Pathways Endnotes” text=”” margin_top=”40″ icon_color=”#f7941d” h_icon_color=”#f7941d” heading_color=”#f7941d” heading_h_color=”#f7941d” heading_f_size=”24px” heading_f_weight=”600″ heading_l_height=”30px” heading_t_transform=”none” icon=”fa-page”][\/cesis_icon_paragraph][\/vc_column][vc_column width=”1\/2″][cesis_breadcrumb pos=”cesis_breadcrumb_right” force_font=”custom” bread_color=”#2c5d73″ bread_hover_color=”#2c5d73″ f_size=”10px” f_weight=”300″ t_transform=”uppercase” margin_bottom=”20″][\/vc_column][\/vc_row][vc_row full_width=”stretch_row_content_no_spaces” gap=”20″ equal_height=”yes” css=”.vc_custom_1601575903140{margin-top: 0px !important;padding-top: 0px !important;padding-right: 20px !important;}”][vc_column width=”1\/4″ css=”.vc_custom_1601575964460{padding-top: 8px !important;padding-right: 8px !important;padding-bottom: 8px !important;padding-left: 8px !important;background-color: #f5f5f5 !important;}”][cesis_icon i_size=”20″ position=”i_float_left” margin_right=”10″ icon_color=”#f7941d” icon=”fa-page”][vc_column_text font_size=”16px” text_resize=”yes” text_minimum=”10″ line_height=”1.25em” font_color=”#2c5d73″ css=”.vc_custom_1616613783509{margin-top: 0px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;}”]Clinical Pathways and Documentation<\/strong>[\/vc_column_text][vc_wp_custommenu nav_menu=”24″][\/vc_column][vc_column width=”3\/4″ css=”.vc_custom_1601575929261{border-radius: 4px !important;}”][vc_column_text css=”.vc_custom_1622593929805{padding-top: 20px !important;padding-right: 20px !important;padding-bottom: 20px !important;padding-left: 20px !important;}”]<\/p>\n

    \n
  1. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines<\/a>. National Institutes of Health. Accessed March 15, 2021.<\/li>\n
  2. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19<\/a>. Accessed March 15, 2021.<\/li>\n
  3. Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19<\/a>. Blood Adv. 2021;5(3):872-888. doi: 10.1182\/bloodadvances.2020003763<\/li>\n
  4. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America<\/a>. Am J Respir Crit Care Med. 2019;200(7):e45-e67. doi: 10.1164\/rccm.201908-1581ST<\/li>\n
  5. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California<\/a>. JAMA. 2020;323(21):2195-2198. doi: 10.1001\/jama.2020.7202<\/li>\n
  6. Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series<\/a>. BMJ. 2020;369:m1996. doi: 10.1136\/bmj.m1996<\/li>\n
  7. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis<\/a>. PLoS Med. 2020;17(9):e1003346. doi: 10.1371\/journal.pmed.1003346<\/li>\n
  8. Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms<\/a>. JAMA Netw Open. 2021;4(1):e2035057. doi: 10.1001\/jamanetworkopen.2020.35057<\/li>\n
  9. Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic<\/a>. Centers for Disease Control and Prevention. Accessed March 15, 2021.<\/li>\n
  10. Hanson KE, Caliendo AM, Arias CA, et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: molecular diagnostic testing<\/a>. Infectious Diseases Society of America. Accessed March 15, 2021.<\/li>\n
  11. Hanson KE, Caliendo AM, Arias CA, et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: serologic testing<\/a>. Infectious Diseases Society of America. Accessed April 27, 2021.<\/li>\n
  12. Wynants L, Calster BV, Collins GS, et al. Prediction models for diagnosis and prognosis of COVID-19: systematic review and critical appraisal<\/a>. BMJ. 2020;369:m1328. doi: 10.1136\/bmj.m1328<\/li>\n
  13. Chow DS, Glavis-Bloom J, Soun JE, et al. Development and external validation of a prognostic tool for COVID-19 critical disease<\/a>. PLoS ONE. 2020;15(12): e0242953. doi: 10.1371\/journal.pone.0242953<\/li>\n
  14. Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score<\/a>. BMJ. 2020;370:m3339. doi: 10.1136\/bmj.m3339<\/li>\n
  15. Artero A, Madrazo M, Fern\u00e1ndez-Garc\u00e9s M, et al. Severity scores in COVID-19 pneumonia: a multicenter, retrospective, cohort study<\/a>. J Gen Intern Med. 2021;36(5):1338-1345. doi: 10.1007\/s11606-021-06626-7<\/li>\n
  16. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19 \u2014 final report<\/a>. N Engl J Med. 2020;383(19):1813-1826. doi:10.1056\/NEJMoa2007764<\/li>\n
  17. WHO Solidarity Trial Consortium. Repurposed antiviral drugs for Covid-19 \u2014 Interim WHO Solidarity Trial results<\/a>. N Engl J Med. 2021;384(6):497-511. doi: 10.1056\/NEJMoa2023184<\/li>\n
  18. Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention<\/a>. Nat Rev Immunol. 2020;20(6):363-374. doi: 10.1038\/s41577-020-0311-8<\/li>\n
  19. Griffin DO, Brennan-Rieder D, Ngo B, et al. The importance of understanding the stages of COVID-19 in treatment and trials<\/a>. Aids Rev. 2021;23(1):40-47. doi: 10.24875\/AIDSRev.200001261<\/li>\n
  20. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury<\/a>. Lancet. 2020;395(10223):473-475. doi: 10.1016\/S0140-6736(20)30317-2<\/li>\n
  21. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects<\/a>. PLOS Med. 2006;3(9):e343. doi: 10.1371\/journal.pmed.0030343<\/li>\n
  22. RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19<\/a>. N Engl J Med. 2021;384(8):693-704. doi:10.1056\/NEJMoa2021436<\/li>\n
  23. Group TRC, Horby PW, Estcourt L, et al. Preprint: Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial<\/a>. medRxiv. 2021; 03.09.21252736. doi: 10.1101\/2021.03.09.21252736<\/li>\n
  24. CONCOR-1. Press Release: Recruitment for the CONCOR-1 trial is now complete<\/a>. CONCOR. Accessed April 27, 2021.<\/li>\n
  25. REMAP-CAP. Press Release: Convalescent Plasma for COVID-19. REMAP-CAP Trial<\/a>. Accessed April 27, 2021.<\/li>\n
  26. Libster R, P\u00e9rez Marc G, Wappner D, et al. Early high-titer plasma therapy to prevent severe Covid-19 in older adults<\/a>. N Engl J Med. 2021;384(7):610-618. doi: 10.1056\/NEJMoa2033700<\/li>\n
  27. ACTIV-3\/TICO LY-CoV555 Study Group. A neutralizing monoclonal antibody for hospitalized patients with Covid-19<\/a>. N Engl J Med. 2021;384(10):905-914. doi: 10.1056\/NEJMoa2033130<\/li>\n
  28. Cohen MS. Monoclonal antibodies to disrupt progression of early Covid-19 infection<\/a>. N Engl J Med. 2021;384(3):289-291. doi: 10.1056\/NEJMe2034495<\/li>\n
  29. Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19<\/a>. N Engl J Med. 2021;384(9):795-807. doi: 10.1056\/NEJMoa2031994<\/li>\n
  30. Nopp S, Moik F, Jilma B, Pabinger I, Ay C. Risk of venous thromboembolism in patients with COVID\u201019: A systematic review and meta\u2010analysis<\/a>. Res Pract Thromb Haemost. 2020;4(7):1178-1191. doi: 10.1002\/rth2.12439<\/li>\n
  31. Modin D, Claggett B, Sindet-Pedersen C, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction<\/a>. Circulation. 2020;142(21):2080-2082. doi: 10.1161\/CIRCULATIONAHA.120.050809<\/li>\n
  32. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up<\/a>. J Am Coll Cardiol. 2020;75(23):2950-2973. doi: 10.1016\/j.jacc.2020.04.031<\/li>\n
  33. REMAP-CAP, ACTIV-4, ATTACC teams. Press Release: Results of interim analyses of Anticoagulation Domain (multi-platform RCT with ATTACC and ACTIV4 trials)<\/a>. REMAP-CAP Trial. Accessed April 28, 2021. https:\/\/www.remapcap.org\/media<\/li>\n
  34. Caputo ND, Strayer RJ, Levitan R. Early self\u2010proning in awake, non\u2010intubated patients in the emergency department: a single ED\u2019s experience during the COVID\u201019 pandemic<\/a>. Acad Emerg Med. 2020;27(5):375-378. doi:10.1111\/acem.13994<\/li>\n
  35. Elharrar X, Trigui Y, Dols A-M, et al. Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure<\/a>. JAMA. 2020;323(22):2336-2338. doi: 10.1001\/jama.2020.8255<\/li>\n
  36. Sartini C, Tresoldi M, Scarpellini P, et al. Respiratory parameters in patients with COVID-19 after using noninvasive ventilation in the prone position outside the intensive care unit<\/a>. JAMA. 2020;323(22):2338-2340. doi: 10.1001\/jama.2020.7861<\/li>\n
  37. Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 201<\/a>9. J Clin Invest. 2020;130(5):2620-2629. doi: 10.1172\/JCI137244<\/li>\n
  38. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China<\/a>. Intensive Care Med. 2020;46(5):846-848. doi: 10.1007\/s00134-020-05991-x<\/li>\n
  39. Xu B, Fan C, Wang A, et al. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China<\/a>. J Infect. 2020;81(1):e51-e60. doi: 10.1016\/j.jinf.2020.04.012<\/li>\n
  40. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study<\/a>. Lancet. 2020;395(10229):1054-1062. doi: 10.1016\/S0140-6736(20)30566-3<\/li>\n
  41. Nguyen CT, Olson G, Pho MT, et al. Automatic ID consultation for inpatients with COVID-19: point, counterpoint, and a single-center experience. Open Forum Infect Dis<\/a>. 2020;7(ofaa318). doi: 10.1093\/ofid\/ofaa318<\/li>\n
  42. Abbott J, Johnson D, Wynia M. Ensuring adequate palliative and hospice care during COVID-19 surges<\/a>. JAMA. 2020;324(14):1393-1934. doi: 10.1001\/jama.2020.16843<\/li>\n
  43. The Lancet. Palliative care and the COVID-19 pandemic<\/a>. Lancet. 2020;395(10231):1168. doi: 10.1016\/S0140-6736(20)30822-9<\/li>\n
  44. Fadul N, Elsayem AF, Bruera E. Integration of palliative care into COVID-19 pandemic planning<\/a>. BMJ Support Palliat Care. 2021;11(1):40-44. doi: 10.1136\/bmjspcare-2020-002364<\/li>\n
  45. Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS-CoV-2 Infection in Healthcare Settings<\/a>. Centers for Disease Control and Prevention. Accessed March 15, 2021.<\/li>\n<\/ol>\n

    [\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

    [vc_row full_width=”stretch_row_content_no_spaces” equal_height=”yes” content_placement=”bottom” css=”.vc_custom_1601575873299{margin-top: 0px !important;margin-bottom: 0px !important;border-bottom-width: 4px !important;padding-top: 0px !important;padding-right: 20px !important;padding-bottom: 0px !important;padding-left: 20px !important;background-color: #f2f2f2 !important;border-bottom-color: #2c5d73 !important;border-bottom-style: solid !important;}”][vc_column width=”1\/2″ css=”.vc_custom_1599240993465{padding-right: 20px !important;padding-left: 10px !important;}”][cesis_icon_paragraph heading=”Clinical Pathways Endnotes” text=”” margin_top=”40″ icon_color=”#f7941d” h_icon_color=”#f7941d” heading_color=”#f7941d” heading_h_color=”#f7941d” heading_f_size=”24px” heading_f_weight=”600″ heading_l_height=”30px” heading_t_transform=”none” icon=”fa-page”][\/cesis_icon_paragraph][\/vc_column][vc_column width=”1\/2″][cesis_breadcrumb pos=”cesis_breadcrumb_right” force_font=”custom” bread_color=”#2c5d73″ bread_hover_color=”#2c5d73″ f_size=”10px” f_weight=”300″ t_transform=”uppercase” margin_bottom=”20″][\/vc_column][\/vc_row][vc_row full_width=”stretch_row_content_no_spaces” […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1232,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/pages\/1263"}],"collection":[{"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/comments?post=1263"}],"version-history":[{"count":5,"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/pages\/1263\/revisions"}],"predecessor-version":[{"id":1294,"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/pages\/1263\/revisions\/1294"}],"up":[{"embeddable":true,"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/pages\/1232"}],"wp:attachment":[{"href":"https:\/\/www.hospitalinnovate.org\/covid19\/wp-json\/wp\/v2\/media?parent=1263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}